Clinical Trials for Epigen

Explore 12 clinical trials worldwide

Showing 1-12 of 12 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Epigen

Clinical Trials (12)

NCT06922318
The COSMYC Trial (COmbined Suppression of MYC)
PHASE2Recruiting
50 participants
Started: Aug 19, 2025 · Completed: Aug 30, 2031
1 condition3 sponsors1 location
NCT07008664
Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Lung Cancer
N/ARecruiting
750 participants
Started: Mar 31, 2025 · Completed: Apr 30, 2032
4 conditions2 sponsors1 location
NCT06745973
An Exploratory Clinical Study Evaluating EPI-003 Injection for the Treatment of Chronic Hepatitis B
EARLY_PHASE1Not yet recruiting
20 participants
Started: Dec 20, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06661148
Study of EPI-003 in Select Nucleos(t)Ide Analogue-Treated, Chronic Hepatitis B Patients
PHASE1Not yet recruiting
36 participants
Started: Dec 1, 2024 · Completed: Jun 30, 2027
2 conditions1 sponsor4 locations
NCT05071937
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
PHASE2Recruiting
33 participants
Started: Apr 21, 2023 · Completed: Mar 1, 2033
3 conditions3 sponsors1 location
NCT05488548
Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological Malignancies
PHASE1Recruiting
75 participants
Started: Dec 21, 2022 · Completed: May 31, 2025
4 conditions1 sponsor6 locations
NCT05607108
A Study of ZEN003694 in People With Squamous Cell Lung Cancer
PHASE2Recruiting
25 participants
Started: Nov 1, 2022 · Completed: Nov 30, 2025
1 condition2 sponsors7 locations
NCT04986423
ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer
PHASE2Recruiting
200 participants
Started: Sep 8, 2021 · Completed: Jun 30, 2026
1 condition3 sponsors31 locations
NCT04471974
ZEN-3694, Enzalutamide, and Pembrolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer
PHASE2Active, not recruiting
61 participants
Started: Jan 26, 2021 · Completed: May 31, 2028
6 conditions4 sponsors3 locations
NCT04145375
Continuation Protocol for ZEN003694 in Patients Experiencing Clinical Benefit While Enrolled in a ZEN003694 Protocol
PHASE1/PHASE2Enrolling by invitation
40 participants
Started: Nov 12, 2019 · Completed: Dec 31, 2026
1 condition1 sponsor2 locations
NCT03999723
Combining Active and Passive DNA Hypomethylation
PHASE2Recruiting
196 participants
Started: Sep 11, 2019 · Completed: Dec 31, 2027
3 conditions14 sponsors10 locations
NCT03682029
Epigenetics, Vitamin C, and Abnormal Blood Cell Formation - Vitamin C in Patients With Low-Risk Myeloid Malignancies
NAActive, not recruiting
109 participants
Started: Nov 21, 2017 · Completed: Sep 27, 2025
3 conditions8 sponsors5 locations